Menopausal Hormone Therapy and breast cancer risk: Individualization is the key to safety.
作者信息
Armeni Eleni, Cano Antonio, Rees Margaret, Lambrinoudaki Irene
机构信息
Second Department of Obstetrics and Gynecology, Aretaieio Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Department of Pediatrics, Obstetrics and Gynecology, University of Valencia and INCLIVA, Valencia, Spain.
出版信息
Maturitas. 2020 Nov;141:85-86. doi: 10.1016/j.maturitas.2020.08.001. Epub 2020 Aug 12.
Abstract
摘要
相似文献
1
Menopausal Hormone Therapy and breast cancer risk: Individualization is the key to safety.更年期激素疗法与乳腺癌风险：个体化是安全的关键。
Maturitas. 2020 Nov;141:85-86. doi: 10.1016/j.maturitas.2020.08.001. Epub 2020 Aug 12.
2
Menopausal Hormone Therapy and Long-term Breast Cancer Risk: Further Data From the Women's Health Initiative Trials.绝经激素治疗与乳腺癌长期风险：来自女性健康倡议试验的更多数据。
JAMA. 2020 Jul 28;324(4):347-349. doi: 10.1001/jama.2020.9620.
3
Bias in Observational Studies of the Association between Menopausal Hormone Therapy and Breast Cancer.更年期激素疗法与乳腺癌关联的观察性研究中的偏倚
PLoS One. 2015 May 4;10(5):e0124076. doi: 10.1371/journal.pone.0124076. eCollection 2015.
4
Menopausal hormone therapy after breast cancer.乳腺癌后的绝经激素治疗。
Lancet. 2004 Feb 7;363(9407):410-1. doi: 10.1016/S0140-6736(04)15519-0.
5
Breast cancer and hormone-replacement therapy: the Million Women Study.乳腺癌与激素替代疗法：百万女性研究
Lancet. 2003 Oct 18;362(9392):1332; author reply 1332. doi: 10.1016/S0140-6736(03)14598-9.
6
Hormone replacement therapy and the risk of breast cancer.激素替代疗法与乳腺癌风险
Eur J Cancer. 2008 Nov;44(16):2344-9. doi: 10.1016/j.ejca.2008.07.041. Epub 2008 Sep 8.
7
8
[Breast cancer and hormone replacement therapy around menopause].[围绝经期乳腺癌与激素替代疗法]
Ned Tijdschr Geneeskd. 2003 Sep 27;147(39):1934-5; author reply 1935.
9
[Menopause: where are we three years beyond WHI?].[绝经：在妇女健康倡议（WHI）发布三年后，我们处于什么阶段？]
Rev Med Suisse. 2006 Feb 15;2(53):467, 469-70, 472 passim.
10
HT and breast cancer risk.激素替代疗法与乳腺癌风险
Fertil Steril. 2003 Oct;80 Suppl 4:5-9; quiz 54-5. doi: 10.1016/j.fertnstert.2003.08.003.
引用本文的文献
1
Identification of Candidate Genes in Breast Cancer Induced by Estrogen Plus Progestogens Using Bioinformatic Analysis.基于生物信息学分析鉴定雌孕激素诱导乳腺癌的候选基因
Int J Mol Sci. 2022 Oct 6;23(19):11892. doi: 10.3390/ijms231911892.
2
Sex hormones and immune system: Menopausal hormone therapy in the context of COVID-19 pandemic.性激素与免疫系统：COVID-19 大流行背景下的绝经激素治疗。
Front Immunol. 2022 Aug 2;13:928171. doi: 10.3389/fimmu.2022.928171. eCollection 2022.
Zotero 插件